Heart failure & cardiomyopathies

Assessing Cardiovascular Benefits of Intensive Blood Pressure Lowering in High-Risk Undiagnosed Heart Failure with Preserved Ejection Fraction (HFpEF) Patients

ESC Heart FailPublished Post-hoc analysis of the SPRINT randomised trial

Authors' conclusion

The HFpEF-ABA score identifies high-risk patients with undiagnosed HFpEF who have elevated cardiovascular event rates and benefit from intensive blood pressure control without an increased risk of serious adverse events.

Study context

Population
SPRINT participants (hypertension), undiagnosed HFpEF risk assessed by HFpEF-ABA score559 primary outcomes
Participants
9,265 participants
Comparison
Intensive vs standard BP control by HFpEF-ABA score
Primary endpoint
Composite of:
  • Myocardial infarction (MI)
  • ACS not resulting in MI
  • Stroke
  • Acute decompensated HF
  • CVD death
Follow-up
Median 3.2 years

Primary result

As reported in the abstract

Adjusted hazard ratio (CI)P value
HFpEF-ABA ≥90%vs HFpEF-ABA <90%
1.96(1.57–2.44)
P < 0.001
Intensive BP controlvs Standardscore <90%
0.75(0.62–0.90)
Intensive BP controlvs Standardscore ≥90%
0.76(0.51–1.13)
P = 0.944for interaction

Per 1000 patient-years

Absolute reduction with intensive treatment, score <90%
5.0
Absolute reduction with intensive treatment, score ≥90%
11.2

Further findings

Primary outcome, HFpEF-ABA score as continuous variable

Higher scores independently associated with increased risk
P = 0.001
Modest non-linear relationship
P for non-linearity = 0.040

Safety

OutcomeaHR (CI)P value
Serious adverse events (intensive vs standard BP control)Intensive BP controlvs StandardScore <90%1.04 (0.96–1.11)
Serious adverse events (intensive vs standard BP control)Intensive BP controlvs StandardScore ≥90%1.06 (0.88–1.28)P for interaction = 0.801

Original publication

Assessing Cardiovascular Benefits of Intensive Blood Pressure Lowering in High-Risk Undiagnosed HFpEF Patients. ESC Heart Fail. Published 7 October 2025. doi:10.1002/ehf2.15435

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.